Clinical Trial Update: RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML

View source ↗

Summary

This clinical trial update investigates whether RFC and MTHFR SNPs and hENT1-dCK expression serve as prognostic factors in acute lymphoblastic leukemia and acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Snippet

Sponsor: National Institute of Cancerología | Conditions: Acute Lymphoblastic Leukemia., Acute Myeloblastic Leukemia | Status: UNKNOWN